Powder: -20°C for 3 years | In solvent: -80°C for 1 year
SC66 is a AKT inhibitor in HepG2, HA22T/VGH, and PLC/PRF/5 cells (IC50: about 0.75 μg/ml, at 72 h).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | In stock | $ 41.00 | |
10 mg | In stock | $ 57.00 | |
25 mg | In stock | $ 97.00 | |
50 mg | In stock | $ 166.00 |
Description | SC66 is a AKT inhibitor in HepG2, HA22T/VGH, and PLC/PRF/5 cells (IC50: about 0.75 μg/ml, at 72 h). |
Targets&IC50 | Akt:0.75 μg/ml |
In vitro | HepG2, HA22T/VGH, and PLC/PRF/5 cells had similar IC50 values of approximately 0.85 and 0.75 μg/ml at 48 and 72 hours for SC66, respectively. The most resistant cell line was Huh7(IC50: 3.1/2.8 μg/ml, at 48/72 h), while the Hep3B cell line was found to be the most sensitive, (IC50: 0.75/0.5 μg/ml, at 48/72 h). SC66 reduced cell viability in a time- and dose-dependent manner inhibited colony formation and induced apoptosis in HCC cells. SC66 treatment led to a reduction in total and phospho-AKT levels. In addition, SC66 induces the production of reactive oxygen species (ROS) and DNA damage. SC66 significantly potentiates the effects of both conventional chemotherapeutic and targeted agents, doxorubicin and everolimus, respectively. [1] |
In vivo | In xenograft models, SC66 can inhibit tumor growth of Hep3B cells. |
Molecular Weight | 276.33 |
Formula | C18H16N2O |
CAS No. | 871361-88-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 20.7 mg/mL(75 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
SC66 871361-88-5 Apoptosis Cytoskeletal Signaling PI3K/Akt/mTOR signaling Akt PKB Protein kinase B Inhibitor inhibit SC-66 SC 66 inhibitor